West Announces Second-Quarter Dividend

West Pharmaceutical Services (NYSE: WST) has announced its second-quarter 2025 dividend payment.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

West Pharmaceutical Services (NYSE: WST) has announced its second-quarter 2025 dividend payment. The company's Board of Directors has approved a dividend of $0.21 per share, which will be paid on May 7, 2025, to shareholders of record as of April 30, 2025. West Pharmaceutical Services is recognized as a global leader in innovative solutions for injectable drug administration.

Positive

Consistent dividend payment demonstrates financial stability
Maintains shareholder returns through quarterly dividend program

Negative

None.

Argus Session date unavailable

+3.56% session move Open Argus

Details

News Market Reaction – WST

The recorded move for WST in the trading session of this news was +3.56%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

02/20/2025 - 04:30 PM

EXTON, Pa., Feb. 20, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2025 dividend of $0.21 per share. The dividend will be paid on May 7, 2025, to shareholders of record as of April 30, 2025.

About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-second-quarter-dividend-302381862.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is West Pharmaceutical Services' dividend amount for Q2 2025?

West Pharmaceutical Services (WST) will pay a dividend of $0.21 per share for the second quarter of 2025.

When is the ex-dividend date for WST's Q2 2025 dividend?

Shareholders must be on record by April 30, 2025, to receive the Q2 2025 dividend payment.

When will WST pay its Q2 2025 dividend?

The Q2 2025 dividend will be paid on May 7, 2025.

Who is eligible for WST's Q2 2025 dividend payment?

Shareholders who are on record as of April 30, 2025, will be eligible to receive the dividend payment.

Keep reading

West Announces Second-Quarter Dividend